mouse il 2 quantikine elisa kit Search Results


il 2 elisa kits  (R&D Systems)
94
R&D Systems il 2 elisa kits
Figure 3. BG34-200 treatment augments systemic activation of T cells recognizing melanoma antigen. (A) Splenocytes or TDLN cells were stimulated with gp10025-33 peptide. IFN-g and IL-2 levels in the culture media were assessed using <t>ELISA.</t> B. Frequencies of CD3, CD4, CD8 T cells and their expression of CD62L and CD44 in spleen and TDLN were determined by FACS analysis. C. TDLN cells were subjected to intracellular cytokine staining for determining the frequency of gp10025-33 -specific T cells. (A) and (B) were graphed as means ± SD. Each data point represents one of three replicates of samples from individual TDLN or spleen. * p < 0.05, ** p < 0.01. Significance was determined using Student’s t test.
Il 2 Elisa Kits, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+il+2+quantikine+elisa+kit/Mouse+IL-2+Quantikine+ELISA+Kit/pm29308312-71-3-9
Average 94 stars, based on 1 article reviews
il 2 elisa kits - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
il 2  (R&D Systems)
95
R&D Systems il 2
Figure 3. BG34-200 treatment augments systemic activation of T cells recognizing melanoma antigen. (A) Splenocytes or TDLN cells were stimulated with gp10025-33 peptide. IFN-g and IL-2 levels in the culture media were assessed using <t>ELISA.</t> B. Frequencies of CD3, CD4, CD8 T cells and their expression of CD62L and CD44 in spleen and TDLN were determined by FACS analysis. C. TDLN cells were subjected to intracellular cytokine staining for determining the frequency of gp10025-33 -specific T cells. (A) and (B) were graphed as means ± SD. Each data point represents one of three replicates of samples from individual TDLN or spleen. * p < 0.05, ** p < 0.01. Significance was determined using Student’s t test.
Il 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+il+2+quantikine+elisa+kit/Mouse+IL-2+Quantikine+ELISA+Kit/10__1161_slash_atvbaha__120__315875-85-8-10
Average 95 stars, based on 1 article reviews
il 2 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

Image Search Results


Figure 3. BG34-200 treatment augments systemic activation of T cells recognizing melanoma antigen. (A) Splenocytes or TDLN cells were stimulated with gp10025-33 peptide. IFN-g and IL-2 levels in the culture media were assessed using ELISA. B. Frequencies of CD3, CD4, CD8 T cells and their expression of CD62L and CD44 in spleen and TDLN were determined by FACS analysis. C. TDLN cells were subjected to intracellular cytokine staining for determining the frequency of gp10025-33 -specific T cells. (A) and (B) were graphed as means ± SD. Each data point represents one of three replicates of samples from individual TDLN or spleen. * p < 0.05, ** p < 0.01. Significance was determined using Student’s t test.

Journal: Oncoimmunology

Article Title: Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer.

doi: 10.1080/2162402X.2017.1387347

Figure Lengend Snippet: Figure 3. BG34-200 treatment augments systemic activation of T cells recognizing melanoma antigen. (A) Splenocytes or TDLN cells were stimulated with gp10025-33 peptide. IFN-g and IL-2 levels in the culture media were assessed using ELISA. B. Frequencies of CD3, CD4, CD8 T cells and their expression of CD62L and CD44 in spleen and TDLN were determined by FACS analysis. C. TDLN cells were subjected to intracellular cytokine staining for determining the frequency of gp10025-33 -specific T cells. (A) and (B) were graphed as means ± SD. Each data point represents one of three replicates of samples from individual TDLN or spleen. * p < 0.05, ** p < 0.01. Significance was determined using Student’s t test.

Article Snippet: Mouse IFN- and IL-2 ELISA kits were purchased from R&D Systems (Minneapolis, MN).

Techniques: Activation Assay, Enzyme-linked Immunosorbent Assay, Expressing, Staining